Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

BACKGROUND: Drug resistance remains a great challenge in the treatment of gastric cancer. The goal of this study was to explore the anti-tumor effects and mechanism of cytokine-induced killer (CIK) cell combined with oxaliplatin (L-OHP) in human oxaliplatin-resistant gastric cancer cells. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qun, Zhang, Hui, Li, Yong, Liu, Jun, Hu, Xiaojie, Fan, Liqiao
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939545/
https://www.ncbi.nlm.nih.gov/pubmed/20799994
http://dx.doi.org/10.1186/1756-9966-29-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939545/
https://www.ncbi.nlm.nih.gov/pubmed/20799994
http://dx.doi.org/10.1186/1756-9966-29-118

Ejemplares similares